Cargando…
The Effect of a Connexin43-Based Peptide on the Healing of Chronic Venous Leg Ulcers: A Multicenter, Randomized Trial
The gap junction protein, connexin43 (Cx43), has critical roles in the inflammatory, edematous, and fibrotic processes following dermal injury and during wound healing, and is abnormally upregulated at the epidermal wound margins of venous leg ulcers (VLUs). Targeting Cx43 with ACT1, a peptide mimet...
Autores principales: | Ghatnekar, Gautam S, Grek, Christina L, Armstrong, David G, Desai, Sanjay C, Gourdie, Robert G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269806/ https://www.ncbi.nlm.nih.gov/pubmed/25072595 http://dx.doi.org/10.1038/jid.2014.318 |
Ejemplares similares
-
Connexin 43-Based Therapeutics for Dermal Wound Healing
por: Montgomery, Jade, et al.
Publicado: (2018) -
Impact of the Controlled Release of a Connexin 43 Peptide on Corneal Wound Closure in an STZ Model of Type I Diabetes
por: Moore, Keith, et al.
Publicado: (2014) -
Evaluation of a connexin-based peptide for the treatment of age-related macular degeneration
por: Obert, Elisabeth, et al.
Publicado: (2022) -
Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1
por: Grek, Christina L, et al.
Publicado: (2015) -
Connexin 43 confers chemoresistance through activating PI3K
por: Pridham, Kevin J., et al.
Publicado: (2022)